| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer
1 company
Kalif Eliyahu Sharon is an EVP, Chief Financial Officer at TEVA. Recent filings cover 0 purchases and 8 sales. Those positions are worth an estimated $2.2M at current prices.
Our model assigns Kalif Eliyahu Sharon a below-average insider score of 37/100, based on 5 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -46.3%.
Kalif Eliyahu Sharon's largest disclosed position is in TEVA as EVP, Chief Financial Officer, worth about $2.2M. The recent filings there lean toward selling, a net 885,324 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, Chief Financial Officer | Sell10b5-1 | 106,563 | $34.10 | $3,633,308.11 | -61.9% | +6.6% | - | |
| May 14, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, Chief Financial Officer | Sell10b5-1 | 153,251 | $35.61 | $5,457,375.39 | -47.1% | +4.0% | - | |
| Feb 26, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, Chief Financial Officer | Sell10b5-1 | 345,810 | $33.64 | $11,634,708.29 | -85.7% | +2.3% | - | |
| Jun 12, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sell10b5-1 | 55,775 | $17.08 | $952,464.10 | -12.1% | +10.5% | - | |
| Feb 28, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE10b5-1 | 55,750 | $16.21 | $903,462.20 | -27.4% | +6.5% | +105.7% | |
| Mar 6, 2024 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE10b5-1 | 77,550 | $13.52 | $1,048,119.27 | -27.6% | +22.9% | +13.5% | |
| Aug 7, 2023 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sell | 35,125 | $9.73 | $341,889.19 | -26.2% | -6.0% | +75.6% | |
| Aug 22, 2022 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sell | 55,500 | $10.07 | $558,696.30 | -85.5% | -13.1% | -4.0% |